Mispricings at Credit Suisse cause $2.85 billion loss

In a statement released on February 19, the bank said the discrepancies, made by a group of its investment bank traders, were uncovered as a result of ongoing control processes. This led to a review of some of its assets, resulting in the latest writedown. The disclosure was made in connection with the closing of $2 billion worth of 5.75% subordinated notes due 2018, on February 19.

These revelations come just days after the bank announced a less than expected Sfr1.3 billion writedown on leveraged finance and structured debt and mortgage investments in the fourth quarter of 2007, signalling that it had managed to ride the wave of the credit crisis better than most of its competitors. The latest writedowns will cut the 2008 first-quarter profits by about $1 billion. The bank is still assessing the impact of these reductions on the 2007 results.

Banks continue to lose billions of dollars due to writedowns on assets exposed to US subprime debt. Losses of more than $145 billion have so far been reported, with estimates running as high as $400 billion.

The Financial Stability Forum (FSF), a committee of international bank regulators and finance ministries, recently called for the strengthening of the financial sector's risk management practices. In interim recommendations to the G-7, released on February 5, “to rebuild confidence in the creditworthiness and robustness of financial institutions”, the FSF said “this involves not only assessing firms’ risk management capacity but also the extent to which firms integrate their risk assessments into their overall decision making processes and controls”.

Credit Suisse has since suspended the traders involved in the mispricing, pending the review.

See also : Credit Suisse contains credit crisis impact
Credit crisis losses could reach $400 billion

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here